Oral evidence transcript
| Published on: | Thursday 14 December 2017 |
|---|---|
| Date: | Tuesday 5 December 2017 |
| Meeting on: | Tuesday 5 December 2017 |
| Part of event segment: | Untitled |
| Document ID: | 156464 |
| Citations: |
|
Committees
Work packages
-
Brexit and the implications for UK business: Pharmaceuticals inquiry
Wednesday 20 September 2017 - Thursday 14 September 2017
Witnesses
-
Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry, John Smith, Chief Executive, Propriety Association of Great Britain, Paul Fleming, Technical Director, British Generic Manufacturers AssociationMark Hicken, Managing Director UK & Ireland for Janssen, Pharmaceutical Companies of Johnson and Johnson, Peter Ballard. Managing Director, Xiromed